Health and Fitness Health and Fitness
Thu, September 23, 2010
[ Thu, Sep 23rd 2010 ] - Market Wire
Covidien Announces Dividend Increase of 11%
[ Thu, Sep 23rd 2010 ] - Market Wire
UnitedHealth Group Schedules Third Quarter Result .. Release and Conference Call for October 19, 2010
[ Thu, Sep 23rd 2010 ] - Market Wire
ZIOPHARM Receives FDA Orphan Drug Designation for .. in in the Treatment of Peripheral T-cell Lymphoma
[ Thu, Sep 23rd 2010 ] - Market Wire
Covidien annuncia il lancio in Europa del ventilatore portatile Puritan Bennetta" 560
[ Thu, Sep 23rd 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Pricing of its P .. Offering of Convertible Senior Subordinated Notes
[ Thu, Sep 23rd 2010 ] - Market Wire
MDS Nordion to Hold Analyst Conference Call to Di .. s Signing of Framework Agreement with JSC Isotope
[ Thu, Sep 23rd 2010 ] - Market Wire
Covidien Announces the Launch of the Puritan Bennetta" 560 Portable Ventilator in Europe
Wed, September 22, 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
CoreSite Realty Corporation Announces Pricing of Initial Public Offering
[ Wed, Sep 22nd 2010 ] - Market Wire
Alcon Launches TobraDex® ST Suspension
[ Wed, Sep 22nd 2010 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Arena Pharmaceuticals, Inc.
[ Wed, Sep 22nd 2010 ] - Market Wire
Data Published Today Reveal That Novel Oral Thera .. Positive Response in Rheumatoid Arthritis Patient
[ Wed, Sep 22nd 2010 ] - Market Wire
AMED Restructures 39 Agencies, Reduces Planned Start-ups
[ Wed, Sep 22nd 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Proposed Public Offering of Convertible Senior Subordinated Notes
[ Wed, Sep 22nd 2010 ] - Market Wire
Alnylam Announces Update on its Board of Directors
[ Wed, Sep 22nd 2010 ] - Market Wire
ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGE .. É(R) STENT IN SMALL VESSELS AND LONG LESIONS
[ Wed, Sep 22nd 2010 ] - Market Wire
ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC P .. CIENTIFIC CORPORATION';S PLATINUM CHROMIUM TAXUS(
[ Wed, Sep 22nd 2010 ] - Market Wire
India Approves Advaxis Trial in Cervix Cancer
[ Wed, Sep 22nd 2010 ] - Market Wire
Cardiovascular Systems Reports Results from Three .. eripheral Clinical Studies at TCT on September 22
[ Wed, Sep 22nd 2010 ] - Market Wire
IMAGING DYNAMICS Completes Rights Offering
[ Wed, Sep 22nd 2010 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Fifth An .. ities Healthcare Conference on September 28, 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
Health Net Again Named to Hispanic Business Magazinea?s Diversity Elite Top 60
[ Wed, Sep 22nd 2010 ] - Market Wire
RXi Pharmaceuticals and EyeGate Pharma Announce C .. Non-Invasive Ocular Delivery of RNAi Therapeutics
[ Wed, Sep 22nd 2010 ] - Market Wire
HEALTH NET APARECE NUEVAMENTE EN EL TOP 60 DE LA .. DE LA DIVERSIDAD DE LA REVISTA HISPANIC BUSINESS
[ Wed, Sep 22nd 2010 ] - Market Wire
Edge Healthcare Partners, LLC Advises Gentiva Hea .. viously Announced Acquisition of Odyssey HealthCa
[ Wed, Sep 22nd 2010 ] - Market Wire
Valeant and Biovail Announce Valeanta?s Intention .. d to Valeant Stockholders upon Obtaining Sharehol
[ Wed, Sep 22nd 2010 ] - Market Wire
St. Jude Medical to Showcase New Lesion Assessment Technology at TCT 2010
[ Wed, Sep 22nd 2010 ] - Market Wire
Medtronica?s Resolute Drug-Eluting Stent Shows Strong Performance in Second aAll Comersa? Study
[ Wed, Sep 22nd 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present at the JMP Healthcare Conference
[ Wed, Sep 22nd 2010 ] - Market Wire
Zalicus to Present at the Fifth Annual JMP Securities Healthcare Conference
[ Wed, Sep 22nd 2010 ] - Market Wire
Aeterna Zentaris to Present at Upcoming Sachs 10t .. l Biotech Europe Investment Forum on September 29

Aeterna Zentaris to Present at Upcoming Sachs 10th Annual Biotech Europe Investment Forum on September 29


Published on 2010-09-22 04:40:54 - Market Wire
  Print publication without navigation


QUÉBEC CITY, Sept. 22 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS,TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will be part of the Oncology Investment panel session at the upcoming Sachs 10th Annual Biotech Europe Investment Forum on Wednesday, September 29, 2010, at 12:00 p.m. (local time), at the Radisson Blu Hotel in Zurich, Switzerland.

That same day, still as part of the Forum, Dr. Engel will also present a corporate overview at 2:15 p.m.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at [ www.aezsinc.com ].

Contributing Sources